Long QT Syndrome Type 2: Emerging Strategies for Correcting Class 2 KCNH2 (hERG) Mutations and Identifying New Patients
Sign Up to like & getrecommendations! Published in 2020 at "Biomolecules"
DOI: 10.3390/biom10081144
Abstract: Significant advances in our understanding of the molecular mechanisms that cause congenital long QT syndrome (LQTS) have been made. A wide variety of experimental approaches, including heterologous expression of mutant ion channel proteins and the… read more here.
Keywords: long syndrome; emerging strategies; syndrome type; kv11 channel ... See more keywords
Dermatologic Manifestations of Neurofibromatosis Type 1 and Emerging Treatments
Sign Up to like & getrecommendations! Published in 2023 at "Cancers"
DOI: 10.3390/cancers15102770
Abstract: Simple Summary Neurofibromatosis type 1 (NF1) is a genetic neurophakomatosis (neuroectodermal disorder) associated with a wide array of skin findings. The most recognizable feature is cutaneous neurofibromas; however, less common dermatologic stigmata may also occur.… read more here.
Keywords: manifestations neurofibromatosis; neurofibromatosis type; emerging treatments; type emerging ... See more keywords